DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.

Pharmaceutical

DURECT

James E. Brown

Neil Verity

Shesh Verma

John Gibson

Jillian H.

Crystal Susa

Julie Fergus

Brenna Stauffer

Susan Autio

Charlie Claycomb

Alex Haedrich

Samantha Bazzell

Jim Brown

Jian Li

Steve Helmer

Timothy M. Papp

Dorothy Engelking

Norman L. Sussman

Andrew R. Miksztal

Weiqi Lin

David J. Ellis

Judy Joice

The Scientific Research and Development team at DURECT focuses on the discovery and advancement of innovative therapies for acute organ injury and chronic liver diseases. This team combines expertise in pharmacology, clinical development, and pharmaceutical research to drive the company's endogenous epigenetic regulator program from concept to clinical trial.

Scientific Research and Development

Leadership Team

Director Team

Scientific Research and Development

About

Team members

Other teams at DURECT

Leadership Team

Director Team